<code id='17816827EB'></code><style id='17816827EB'></style>
    • <acronym id='17816827EB'></acronym>
      <center id='17816827EB'><center id='17816827EB'><tfoot id='17816827EB'></tfoot></center><abbr id='17816827EB'><dir id='17816827EB'><tfoot id='17816827EB'></tfoot><noframes id='17816827EB'>

    • <optgroup id='17816827EB'><strike id='17816827EB'><sup id='17816827EB'></sup></strike><code id='17816827EB'></code></optgroup>
        1. <b id='17816827EB'><label id='17816827EB'><select id='17816827EB'><dt id='17816827EB'><span id='17816827EB'></span></dt></select></label></b><u id='17816827EB'></u>
          <i id='17816827EB'><strike id='17816827EB'><tt id='17816827EB'><pre id='17816827EB'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:93186
          Fetal ultrasound
          Adobe

          The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans.

          The technology is close enough to reality that the Food and Drug Administration has decided to convene a two-day panel starting Tuesday to discuss how to best evaluate safety and effectiveness, as well as the ethical quandaries in running clinical trials. The second day will be closed to the public to shield trade secrets.

          advertisement

          Several research teams are racing to build artificial placentas that replicate the uterine environment and give the very prematurely born a better shot at survival. A team at the Children’s Hospital of Philadelphia, led by Alan Flake, is the closest to human trials — their device is a bag filled with sterile fluid, which contains the fetus and is connected to tubes providing oxygen and nutrition.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Sanofi seeks simpler, safer CRISPR sickle cell cure
          Sanofi seeks simpler, safer CRISPR sickle cell cure

          RubyWallauforSTATSanofiwilllicenseanewCRISPRenzymefromthestartupScribeTherapeuticsinabidtobethefirst

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Biden will tout long

          FILE-TheGrandCanyonNationalParkiscoveredinthemorningsunlightasseenfromahelicopternearTusayan,Ariz.,O